Clinical Trials
9 trialsNCT04971733 2025-06-10
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Phase 1/2 Completed
NCT03089918 2025-04-27
A Study to Investigate the Regional Brain Kinetics of Brain Drug Transporters Using P-glycoprotein and Breast Cancer Resistance Protein Substrates and by Using the Positron Emission Tomography Ligand 11C-JNJ-63779586 in the Human Brain
Janssen Research & Development, LLC
Phase 1 Completed
NCT04571697 2025-04-27
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
Janssen Research & Development, LLC
Completed
NCT05328115 2025-01-31
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Alzinova AB
Phase 1 Completed
NCT02632786 2019-04-05
PRONTO
Prothena Biosciences Ltd.
Phase 2 Completed
NCT00348140 2017-09-05
REFLECT-3
GlaxoSmithKline
Phase 3 Completed
NCT02859207 2017-06-08
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Eisai Inc.
Phase 1 Completed
NCT00428090 2017-05-19
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
GlaxoSmithKline
Phase 3 Completed
NCT00411580 2013-03-29
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Novartis
Phase 1 Completed